-
Hematopoietic Tet2 inactivation enhances the response to checkpoint blockade immunotherapy
Study
EGAS50000001191
-
Dual inhibition of FLT3 and BCL-2 is effective in preclinical models of BCL11B-activated lineage ambiguous leukemia
Study
EGAS50000000978
-
Translational analyses from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Study
EGAS50000001165
-
Transcriptomic dataset from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dataset
EGAD50000001664
-
Data Access Committee for Translational analyses from a phase II study of pembrolizumab and epigenetic modification with azacitidine in platinum-resistant epithelial ovarian cancer
Dac
EGAC50000000697
-
Head and neck tumor organoid biobank for modelling individual responses to radiation therapy according to the TP53/ HPV status
Study
EGAS50000001219
-
CNA differences between RNA-based subtypes of PDAC
Study
EGAS50000001218
-
Ultra-sensitive tumor-informed ctDNA monitoring of treatment response in advanced esophagogastric cancer patients
Study
EGAS50000001224
-
Data Access Committee for Triple Negative Breast Cancer dataset
Dac
EGAC00001003584
-
Microarray CDX or EDX from primary tumor and metastasis
Dataset
EGAD00010002711